No phaseStatus unknown
Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria (Steno-2)
- Sponsor
- Peter Gæde (Academic or other)
- Enrollment
- 160 enrolled
- Conditions
- Type 2 Diabetes
- Interventions
- Diet; Exercise; Stop smoking; Glucose lowering therapy; Blood pressure lowering therapy; Lipid lowering therapy
- Ages
- adults, older adults
- Registry
- NCT00320008
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to determine whether intensified multifactorial intervention comprising both behaviour modification and polypharmacy can reduce the risk for late diabetic complications compared to standard treatment in patients with type 2 diabetes and microalbuminuria.
Primary outcomes
- Diabetic nephropathy
- Combined cardiovascular endpoint
- Total mortality
- Years of life years gained
History
Study completion
Last registry update
Registered
Primary completion
Started
Papers citing this trial
- A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study
Diabetologia
- Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
Diabetologia